Loading clinical trials...
Loading clinical trials...
The purpose of the study is to evaluate the therapeutic benefit and safety of intratympanic AM-101 injections in comparison to placebo in the treatment of persistent acute inner ear tinnitus.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Auris Medical, Inc.
NCT06782308 · Tinnitus, Subjective, Tinnitus, Bilateral, and more
NCT04066348 · Tinnitus, Noise Induced
NCT07393880 · Tinnitus, Subjective, Tinnitus, and more
NCT07071480 · Tinnitus, Tinnitus, Subjective
NCT06880367 · Tinnitus, Subjective
University of Florida College of Medicine
Gainsville, Florida
University of Kansas Medical Center
Kansas City, Kansas
Advanced ENT & Allergy
Louisville, Kentucky
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions